Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDE4A | P27815 | 13/20 | 0.47 |
| ▸ | PDE4D | Q08499 | 2/20 | 0.45 |
| ▸ | PDE4B | Q07343 | 1/20 | 0.45 |
| ▸ | PDE4C | Q08493 | 1/20 | 0.45 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | CRHBP | P24387 | 1/20 | 0.43 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.43 |
| ▸ | TP53 | P04637 | 1/20 | 0.40 |
| ▸ | HTT | P42858 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3827265 | 0.84 | BACE1 (0.48) | MAPTHTT | |
| SCHEMBL1659533 | 0.79 | PDE4A (0.48) | PDE4APDE4DPDE4BPDE4C | |
| SCHEMBL11283904 | 0.74 | TDP1 (0.57) | PDE4APDE4DPDE4BPDE4CMAPT | |
| SCHEMBL11284890 | 0.73 | TDP1 (0.53) | PDE4APDE4DPDE4BPDE4CMAPT | |
| SCHEMBL8925196 | 0.73 | PDE4A (0.74) | PDE4APDE4DPDE4BPDE4C | |
| SCHEMBL29184115 | 0.70 | TNF (0.59) | PDE4APDE4DPDE4BPDE4CMAPT | |
| SCHEMBL8784548 | 0.70 | LDHA (0.60) | PDE4APDE4DPDE4BPDE4C | |
| SCHEMBL7389132 | 0.69 | PDE4A (0.49) | PDE4APDE4DPDE4BPDE4CMAPT | |
| SCHEMBL6755365 | 0.69 | PDE4A (0.79) | PDE4APDE4DPDE4BPDE4C | |
| SCHEMBL29174154 | 0.68 | TNF (0.60) | PDE4APDE4DPDE4BPDE4CMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1807396-A4 | 2-AMINOPYRIDINE COMPOUNDS USEFUL AS BETA-SECRETASE INHIBITORS FOR THE TREATMENT OF ALZHEIMER'S DISEASE | MERCK & CO INC (US) | 2009-09-09 | — | — | EP | disclosed |
| EP-1807396-A1 | 2-AMINOPYRIDINE COMPOUNDS USEFUL AS BETA-SECRETASE INHIBITORS FOR THE TREATMENT OF ALZHEIMER'S DISEASE | Merck & Co., Inc. (US) | 2007-07-18 | — | — | EP | disclosed |
| WO-2006060109-A1 | 2-AMINOPYRIDINE COMPOUNDS USEFUL AS BETA-SECRETASE INHIBITORS FOR THE TREATMENT OF ALZHEIMER'S DISEASE | MERCK & CO., INC. (US) | 2006-06-08 | — | — | WO | disclosed |